Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
about
Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis.Letrozole therapy alone or in sequence with tamoxifen in women with breast cancerShould aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?Aromatase inhibitors in early breast cancer therapy: a variety of treatment strategies.Aromatase inhibitors: a safety comparison.Aromatase inhibitors in post-menopausal metastatic breast carcinoma.Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations.To switch or not to switch: should the updated Intergroup Exemestane Study alter our decision?Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women.Selective fraction of Scutellaria baicalensis and its chemopreventive effects on MCF-7 human breast cancer cells.Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line.Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update.Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer.
P2860
Q25257781-BB207C23-60CB-4E7C-9B92-A47A94CDD86AQ33828149-9F80EB4A-112E-42CA-A198-17248AB737D4Q34066531-04A61BD3-D49C-4080-990D-FA13425901CEQ36376788-7AD91FD6-272A-416F-A2D1-9D1AD6EFCC9DQ36675384-538C7AF2-55B2-4013-A52E-E80ECA1A9A30Q36762444-D0F998A1-EFC5-42B1-BA1D-256D2CB274BCQ36861597-0FFA1B52-DAD3-42AC-92F3-9371A4F57312Q36967279-30C017E9-E23C-4EEA-A867-5848A23CB6A3Q37038875-2DB14DEC-7E3F-4FD7-B12A-9FFA3CCC61B6Q37366511-04FD8F9F-6774-48E2-A34E-B6C144E062A6Q37461123-DB3B529A-87F0-440D-9669-C9F55C7E20E5Q39806060-70196C0F-3EED-47F3-98E8-4191B31ACDD5Q43253910-0E7771A8-6613-494E-8B93-E43118D8076BQ43267053-3F01B1A7-0D55-43B7-B466-8923CA4D3586
P2860
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@en
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@nl
type
label
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@en
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@nl
prefLabel
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@en
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@nl
P2093
P356
P1476
Optimizing adjuvant endocrine ...... t cancer: a decision analysis.
@en
P2093
Eric P Winer
Harold J Burstein
Jane C Weeks
Karen M Kuntz
Rinaa S Punglia
P304
P356
10.1200/JCO.2005.02.964
P407
P577
2005-07-05T00:00:00Z